New England Research & Management, Inc.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1596077
CHICAGO, IL
Position in TMO
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,297,519
+$602,988 QoQ
Shares Held
2,588
+83.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,334
of 2,606 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $1,976,509 across 3 Diagnostics & Research names. TMO ranks #1 (65.6% of the industry book) .
All Filings in TMO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,297,519 | 2,588 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $694,531 | 1,413 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,270,733 | 2,193 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,165,503 | 2,403 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,033,112 | 2,548 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $985,745 | 1,981 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $382,369 | 735 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,370,132 | 2,215 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $630,420 | 1,140 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $348,726 | 600 | Shares | Sole | 2024-04-16 | |
| 2020-06-30 | $769,972 | 2,125 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $602,650 | 2,125 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||